TNF and mastitis: Ershun et al. demonstrated CEP’s anti-inflammatory properties using an in vivo mouse model of mastitis and showing that CEP reduced the levels of tumor necrosis factor α (TNF-α), interleukin-1β (IL-1β), and interleukin-6 (IL-6) through an attenuation of the natural inflammatory response [16].